2,889
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors

, , , , &
Article: e1168557 | Received 18 Feb 2016, Accepted 14 Mar 2016, Published online: 15 Jun 2016